Preoperative Denosumab may increase the Risk of Local Recurrence of Giant-cell Tumor of Bone Treated with Curettage: A Systematic Review and Meta-analysis

Conclusions: Preoperative denosumab may increase the risk of local recurrence of GCTB treated with curettage and should be used with caution in the management of GCTB.

Source: Journal of Cancer - January 15, 2021 Category: Cancer & Oncology Authors: Yongzhao Zhao, Zhenyu Cai, Xiaodong Tang, Zhiye Du, Yi Yang, Wei Guo Tags: Research Paper Source Type: research